JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area mapk raf'

Search results for: 'research area mapk raf'

A5071 GDC-0879

1 Citation

Target: Raf

Summary: B-Raf inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
A3016 PLX-4720

1 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥20.69 mg/mL
A3009 Sorafenib

2 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥23.25 mg/mL
A3004 Vemurafenib (PLX4032, RG7204)

9 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥24.5 mg/mL
A1632 SB202190 (FHPI)

5 Citation

Target: p38

Summary: P38 MAPK inhibitor
A5566 LY2228820

1 Citation

Target: p38

Summary: P38 MAP kinase inhibitor

≥30.65 mg/mL
A3018 Trametinib (GSK1120212)

7 Citation

Target: MEK

Summary: MEK1 and MEK2 inhibitor, potent and selective

insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
A5801 BIX 02189

Target: MEK|ERK

Summary: Selective MEK5 inhibitor

≥22.05 mg/mL
A8236 Regorafenib

4 Citation

Target: Raf|VEGFR|PDGFR|c-Kit|RET

Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1

≥25.04 mg/mL
A8683 NVP-BHG712

Target: Eph Receptors|VEGFR

Summary: EphB4 inhibitor,potent and selective

≥25.15 mg/mL